As we were primarily interested in hypomethylation associated with overexpression, BAHCC1 was excluded from the methylation/expression validation, because its expression levels were undetectable in AML as well as in healthy donors’ samples according to microarray expression data. Here, BAHCC1 is linked to acute myeloid leukemia.